C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
11/2006
11/02/2006	WO2002044994A3 Systems and methods for detection assay ordering, design, production, inventory, sales and analysis for use with or in a production facility
11/02/2006	US20060248617 Method of targeted gene disruption, genome of hyperthermostable bacterium and genome chip using the same
11/02/2006	US20060248614 Implementation of a mitochondrial mutator
11/02/2006	US20060248613 Implementation of a mitochondrial mutator
11/02/2006	US20060248611 Altered fad2 and fad3 genes in brassica and the molecular marker-assisted detection thereof
11/02/2006	US20060248609 DNAs coding for flavone synthases, methods of using flavone synthase DNAs, and plants, flowers, and vectors containing flavone synthase DNAs
11/02/2006	US20060248605 Beta-amyloid peptide-binding proteins and polynucleotides encoding the same
11/02/2006	US20060248603 Novel fibrillin-like polypeptides
11/02/2006	US20060248602 Contacting polynucleotide with acetylthiourea, N,N-dimethylthioformamide, N,N'-diphenylthiourea, N-ethylthiourea, 2-imidazolidinethione, 4(6)-methyl-2-thiouracil, N-methylthiourea, phenylthio-carbamid, 6-phenyl-2-thiouracil, 6-propyl-2-thiouracil, tetramethylthiourea, thioacetamide, thioacetanilide
11/02/2006	US20060247431 Activators for oligonucleotide and phosphoramidite synthesis
11/02/2006	US20060247430 Methods and compounds for polynucleotide synthesis
11/02/2006	US20060247429 Synthesizing a double stranded nucleic acid molecule used for treatment of any disease that responds to modulation of gene expression, for example cancer, proliferative, inflammatory, metabolic, autoimmune, neurologic, ocular diseases; in vivo stability and bioavailability
11/02/2006	US20060247428 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
11/02/2006	US20060247425 Glycosylated immunoglobulin and immunoadhesin comprising the same
11/02/2006	US20060247421 Liver x receptor alpha splicing mutant protein, gene thereof and utilization of the same
11/02/2006	US20060247420 Immune cell recptor ligand and immune cell receptor
11/02/2006	US20060247419 Translocation dependent complementation for drug screening
11/02/2006	US20060247418 Gfp fusion proteins and their use
11/02/2006	US20060247416 HIV gp41 HR2-derived synthetic peptides, and their use in therapy to inhibit transmission of human immunodeficiency virus
11/02/2006	US20060247202 Expression vector for use as regulatory tool in genetic engineering; useful for reducing the expression of endogenous mRNA and any substantially similar endogenous mRNA
11/02/2006	US20060247198 TGF-beta type receptor cDNAs encoded products and uses therefor
11/02/2006	US20060247194 Rna interference mediated treatment of alzheimer's disease using short interfering nucleic acid (sina)
11/02/2006	US20060247191 Chimeric cytoplasmic signalling molecules
11/02/2006	US20060246561 Adh from rhodococcus erythropolis
11/02/2006	US20060246548 CE7-specific redirected immune cells
11/02/2006	US20060246547 Nematode-extracted serine protease inhibitors and anticoagulant proteins
11/02/2006	US20060246545 Gene inactivated mutants with altered protein production
11/02/2006	US20060246543 Slim compositions and methods of use thereof
11/02/2006	US20060246542 System for antibody expression and assembly
11/02/2006	US20060246541 eukaryotic proteins that require formation of disulfide bridges for biological activity; comprising a thioredoxin located N-terminal to the domain
11/02/2006	US20060246540 Monoclonal, humanized, fragmented or labeled antibodies; extracellular proteins; expression vectors; host cells
11/02/2006	US20060246539 Protein production method utilizing yebF
11/02/2006	US20060246538 Capable of sodium-independently transporting branched amino acids
11/02/2006	US20060246521 Serum tumor marker in rodent prostate cancer models
11/02/2006	US20060246519 For use in the capture and/or purification of biotinylated proteins
11/02/2006	US20060246509 Unnatural reactive amino acid genetic code additions
11/02/2006	US20060246506 Non-competitive immunoassay for small analytes
11/02/2006	US20060246504 Detection and treatment of polycystic kidney disease
11/02/2006	US20060246502 Screening for a material that promotes or inhibits binding between a rabconnectin-3-binding protein having a specific amino acid sequence and rabconnectin-3 and therefore would be useful for regulating Ca2+-dependent exocytosis
11/02/2006	US20060246500 Polynucleotide detection method employing self-reporting dual inversion probes
11/02/2006	US20060246498 HNRPLL polypeptides, polynucleotides encoding same and compositions and methods of using same
11/02/2006	US20060246491 Micro-RNA's that regulate muscle cells
11/02/2006	US20060246486 Human signal peptide-containing proteins
11/02/2006	US20060246483 Identifying and characterizing novel human secreted proteins and their genes ; promotes vascularization; screening methods
11/02/2006	US20060246482 Linker molecules for selective metallisation of nucleic acids and their uses
11/02/2006	US20060246477 Method for generating variable domain sequences of heavy chain antibodies
11/02/2006	US20060246473 Specific to Bordetella pertussis, Chlamydophila pneumoniae, Haemophilus influenzae, Klebsiella pneumoniae, Legionella pneumophila, Moraxella catarrhalis, Mycoplasma pneumoniae, Pseudomonas aeruginosa, Stapylococcus aureus, and Streptococcus pneumoniae; microarrays
11/02/2006	US20060246472 Method for the detection of predisposition to high altitude pulmonary edema
11/02/2006	US20060246471 Compositions and methods for screening pro-apoptotic compounds
11/02/2006	US20060246468 enzyme inhibitors; useful in the production of carbohydrate chains within glycoproteins/glycolipids; detecting, or inhibiting the production of, the alpha -1,3-fucosyltransferase which involves the use of cDNA coding the enzyme
11/02/2006	US20060246465 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/02/2006	US20060246461 Nucleotide sequence coding membrane protein; diagnosis of tumor, cancer
11/02/2006	US20060246460 Nucleic acid sequence identification
11/02/2006	US20060246456 Fucose transporter
11/02/2006	US20060246453 Method of synthesizing cdna
11/02/2006	US20060246452 Method for identifying nucleic acid molecules associated with angiogenesis
11/02/2006	US20060246450 Ligational encoding of small molecules
11/02/2006	US20060246449 Dna sequence analysis
11/02/2006	US20060246442 Using zinc transporter protein-8 to identify modulators for treatment and diagnosis of diabetic disorders
11/02/2006	US20060246438 Methods for the chemical and physical modification of nanotubes, methods for linking the nanotubes, methods for the directed positioning of nanotubes, and uses thereof
11/02/2006	US20060246432 Methods and materials for modulating task-3
11/02/2006	US20060246428 Polynucleotide probe and primer derived from hepatitis E virus recovered from japanese, chip including the same, kit including the same, and method of detecting hepatitis E virus genome using the same
11/02/2006	US20060246426 Recombinant fusion proteins with high affinity binding to gold and applications thereof
11/02/2006	US20060246422 Methods and compositions for use in spliceosome mediated RNA trans-splicing
11/02/2006	US20060246125 Proteoliposome for use as gene transfer tool in treatment and diagnosis of cardiomyopathy, type II diabetes, Alzheimer's, Parkinson's diseases; gene therapy
11/02/2006	US20060246123 Oligonucleotide mimetics
11/02/2006	US20060246095 Multiepitope polypeptides for cancer immunotherapy
11/02/2006	US20060246087 A fusion monomer of fusion protein of an antigen derived from an envelope protein of Japanese encephalitis virus and an amino acid sequence of a mucous membrane-binding protein monomer; industrial scale; purification efficiency; recombinant mucosal vaccine; intestinal immunization by oral administration
11/02/2006	US20060246077 Use of antibodies against the MUC18 antigen
11/02/2006	US20060246069 Inflammation and immunopathy caused by human anti-human Monocyte chemoattractant protein-1
11/02/2006	US20060246068 Polypeptides having a triggering NK activity and biological applications
11/02/2006	US20060246067 Immunomodulatory constructs and their uses
11/02/2006	US20060246065 Fail molecules and uses thereof
11/02/2006	US20060246064 monoclonal antibodies; treat bone diseases characterized by changes in bone resorption, such as osteoporosis, hypercalcemia, bone loss due to arthritis metastasis, immobilization or periodontal disease, Paget's disease; denosumab
11/02/2006	US20060246051 Male reproductive disorders including proliferative disorders of testes
11/02/2006	US20060246049 Compositions and methods for enzymatic detachment of bacterial and fungal biofilms
11/02/2006	US20060246048 Elongation of fatty acids(ELF) polypeptides and carrier mixtures administered for prophylaxis of vision defects
11/02/2006	US20060246047 Peptide wirh apoptosis-inhibiting activity
11/02/2006	US20060246039 Growth differentiation factor-7
11/02/2006	US20060246024 Method for stimulating hair follicle cell proliferation
11/02/2006	US20060246004 Antibody variants and uses thereof
11/02/2006	EP1717323A2 Infectious etiologic agent detection probe and probe set, carrier, and genetic screening method
11/02/2006	EP1717316A1 Interferon-like protein ZCYTO21
11/02/2006	EP1717314A1 Receptor for modified low-density lipoprotein
11/02/2006	EP1717245A1 T-cell epitopes from the oncofetal antigen-immature laminin receptor protein and medical uses thereof
11/02/2006	EP1717243A1 Uses of cationic salts for polynucleotide synthesis
11/02/2006	EP1717242A1 Polynucleotide synthesis
11/02/2006	EP1716256A2 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis
11/02/2006	EP1716250A2 Determination of hepatitis c virus genotype
11/02/2006	EP1716179A2 Monoclonal antibodies that specifically bind to folate receptor alpha
11/02/2006	EP1716165A2 Expression of apoa-1 and variants thereof using spliceosome mediated rna trans - splicing
11/02/2006	EP1716164A1 Targeted delivery of rna interference molecules for the treatment of ige-mediated disorders
11/02/2006	EP1715971A1 Functionalized colloidal metal compositions and methods
11/02/2006	EP1715736A2 Polypeptides having xylanase activity and polynucleotides encoding same
11/02/2006	EP1597383A4 Variants of cytochrome c and methods of diagnosis of thrombocytopenia
11/02/2006	EP1105157B1 Protein delivery system using human papillomavirus virus-like particles
11/02/2006	EP1009834B1 Regulation of protein secretion
11/02/2006	EP0854722B1 Proteins involved in targeting of peptidyl transfer center, and corresponding therapeutic agents and methods
11/02/2006	CA2609788A1 Modified oligoribonucleotide analogs with enhanced immunostimulatory activity
11/02/2006	CA2609695A1 Ubiquilin regulation of presenilin endoproteolysis, and suppression of polyglutamine-induced toxicity in cells

1 ... 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 ... 899